by CalmUmberBison1mo agoUSDG pair0x319eaa…9b7c8b
Roivant Sciences — Vivek Ramaswamy's biotech holding company. Stock +19% on Sept 8, 2026 after a positive Phase 3 in pulmonary hypertension (Pulmovant).
Reading trades.